Table 5.
Multivariate logistic regression analysis of clinical variables associated with disease severity in patients with COVID-19.
| Enteral nutrition group(n=48) | Parenteral nutrition group(n=23) | P value | Multivariate | |
|---|---|---|---|---|
| P value | ||||
| Arterial oxygen concentration (at rest) | 96.96 ± 4.32 | 92.47 ± 9.06 | 0.006 | 0.958 |
| PaO2/FiO2 (ratio) | 334.66 ± 153.94 | 211.73 ± 115.43 | 0.001 | 0.856 |
| Respiratory index | 1.26 ± 1.35 | 2.86 ± 2.34 | <0.001 | 0.592 |
| Comorbidities (n, %) | ||||
| Hypertension | 23(47.9) | 10(43.5) | 0.726 | 0.571 |
| Diabetes mellitus II | 17(35.4) | 5(21.7) | 0.243 | 0.101 |
| Chronic cardiac disease | 6(12.5) | 5(21.7) | 0.319 | 0.446 |
| Chronic obstructive lung disease | 3(6.3) | 0(0.0) | 0.546 | 0.552 |
| Cancer | 5(10.4) | 1(4.3) | 0.656 | 0.105 |
| Albumin, g/L | 33.84 ± 4.97 | 30.45 ± 5.07 | 0.009 | 0.326 |
| White blood cell count | 7.69 ± 3.83 | 10.25 ± 5.95 | 0.032 | 0.626 |
| Neutrophil cell count, ×109/L | 5.68 ± 3.74 | 8.26 ± 5.29 | 0.020 | 0.832 |
| Procalcitonin, ng/mL | <0.001 | 0.109 | ||
| Normal | 41(85.4) | 10(43.5) | ||
| Elevated | 7(14.6) | 13(56.5) | ||
| Complications during hospitalization (n, %) | 5(10.4) | 16(69.6) | <0.001 | <0.001 |
| Outcomes | ||||
| Respiratory failure (n, %) | 5(10.4) | 13(56.5) | <0.001 | 0.847 |
| Shock (n, %) | 0(0.0) | 11(47.8) | <0.001 | 0.251 |
| Organ failure (n, %) | 1(2.1) | 13(56.5) | <0.001 | <0.001 |
The meaning of the values in bold is the P-value is less than 0.05.